The European Commission has approved the proposed acquisition of a US-based pharmaceutical and health-care corporation by a French-based pharmaceutical industry company. Brussels gave the green light on Wednesday for the acquisition of Viatris Inc by CVC Capital Partners-owned Cooper Consumer Health SAS, subject to certain conditions. Viatris expects the transaction to be completed in early July. The commission said that the acquisition would have reduced competition in the market for certain pharmaceutical products, and led to high combined market shares as well as high concentration levels i…